nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Optic atrophy—Vincristine—muscle cancer	0.0523	0.0523	CcSEcCtD
Hydroxychloroquine—Abnormal pigmentation—Doxorubicin—muscle cancer	0.0447	0.0447	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Etoposide—muscle cancer	0.0243	0.0243	CcSEcCtD
Hydroxychloroquine—Eruption—Dactinomycin—muscle cancer	0.0182	0.0182	CcSEcCtD
Hydroxychloroquine—Abdominal cramps—Vincristine—muscle cancer	0.0149	0.0149	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Vincristine—muscle cancer	0.0149	0.0149	CcSEcCtD
Hydroxychloroquine—Reaction gastrointestinal—Methotrexate—muscle cancer	0.0146	0.0146	CcSEcCtD
Hydroxychloroquine—Paralysis—Vincristine—muscle cancer	0.0144	0.0144	CcSEcCtD
Hydroxychloroquine—Nystagmus—Vincristine—muscle cancer	0.014	0.014	CcSEcCtD
Hydroxychloroquine—Retinal disorder—Methotrexate—muscle cancer	0.0136	0.0136	CcSEcCtD
Hydroxychloroquine—Pigmentation disorder—Doxorubicin—muscle cancer	0.0126	0.0126	CcSEcCtD
Hydroxychloroquine—Leukoderma—Methotrexate—muscle cancer	0.0114	0.0114	CcSEcCtD
Hydroxychloroquine—Bullous eruption—Doxorubicin—muscle cancer	0.0107	0.0107	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Dactinomycin—muscle cancer	0.0105	0.0105	CcSEcCtD
Hydroxychloroquine—Leukoderma—Doxorubicin—muscle cancer	0.00991	0.00991	CcSEcCtD
Hydroxychloroquine—Appetite absent—Methotrexate—muscle cancer	0.00978	0.00978	CcSEcCtD
Hydroxychloroquine—Cardiovascular disorder—Etoposide—muscle cancer	0.00925	0.00925	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Etoposide—muscle cancer	0.00899	0.00899	CcSEcCtD
Hydroxychloroquine—Cardiomyopathy—Doxorubicin—muscle cancer	0.00823	0.00823	CcSEcCtD
Hydroxychloroquine—Deafness—Vincristine—muscle cancer	0.00814	0.00814	CcSEcCtD
Hydroxychloroquine—Eruption—Methotrexate—muscle cancer	0.00791	0.00791	CcSEcCtD
Hydroxychloroquine—Psoriasis—Methotrexate—muscle cancer	0.00774	0.00774	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Dactinomycin—muscle cancer	0.00752	0.00752	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00734	0.00734	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Methotrexate—muscle cancer	0.00721	0.00721	CcSEcCtD
Hydroxychloroquine—Liver disorder—Methotrexate—muscle cancer	0.00714	0.00714	CcSEcCtD
Hydroxychloroquine—Paralysis—Methotrexate—muscle cancer	0.007	0.007	CcSEcCtD
Hydroxychloroquine—Eruption—Doxorubicin—muscle cancer	0.00685	0.00685	CcSEcCtD
Hydroxychloroquine—Ataxia—Vincristine—muscle cancer	0.00684	0.00684	CcSEcCtD
Hydroxychloroquine—Psoriasis—Doxorubicin—muscle cancer	0.0067	0.0067	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Dactinomycin—muscle cancer	0.00669	0.00669	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Vincristine—muscle cancer	0.00642	0.00642	CcSEcCtD
Hydroxychloroquine—Hypokinesia—Doxorubicin—muscle cancer	0.00624	0.00624	CcSEcCtD
Hydroxychloroquine—Bone marrow depression—Doxorubicin—muscle cancer	0.00624	0.00624	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.00622	0.00622	CcSEcCtD
Hydroxychloroquine—Paralysis—Doxorubicin—muscle cancer	0.00606	0.00606	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Etoposide—muscle cancer	0.00604	0.00604	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Vincristine—muscle cancer	0.00597	0.00597	CcSEcCtD
Hydroxychloroquine—Nystagmus—Doxorubicin—muscle cancer	0.0059	0.0059	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Dactinomycin—muscle cancer	0.00586	0.00586	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Vincristine—muscle cancer	0.00574	0.00574	CcSEcCtD
Hydroxychloroquine—Weight decreased—Vincristine—muscle cancer	0.00569	0.00569	CcSEcCtD
Hydroxychloroquine—Depression—Vincristine—muscle cancer	0.00559	0.00559	CcSEcCtD
Hydroxychloroquine—Scotoma—Doxorubicin—muscle cancer	0.00555	0.00555	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Methotrexate—muscle cancer	0.00539	0.00539	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Dactinomycin—muscle cancer	0.00533	0.00533	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00531	0.00531	CcSEcCtD
Hydroxychloroquine—Blood disorder—Doxorubicin—muscle cancer	0.00504	0.00504	CcSEcCtD
Hydroxychloroquine—Bronchospasm—Etoposide—muscle cancer	0.00501	0.00501	CcSEcCtD
Hydroxychloroquine—Alopecia—Dactinomycin—muscle cancer	0.00498	0.00498	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Etoposide—muscle cancer	0.00484	0.00484	CcSEcCtD
Hydroxychloroquine—Cardiovascular disorder—Doxorubicin—muscle cancer	0.0048	0.0048	CcSEcCtD
Hydroxychloroquine—Skin discolouration—Doxorubicin—muscle cancer	0.00466	0.00466	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Methotrexate—muscle cancer	0.00457	0.00457	CcSEcCtD
Hydroxychloroquine—Anaemia—Dactinomycin—muscle cancer	0.00454	0.00454	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00451	0.00451	CcSEcCtD
Hydroxychloroquine—Alopecia—Vincristine—muscle cancer	0.00445	0.00445	CcSEcCtD
Hydroxychloroquine—Mental disorder—Vincristine—muscle cancer	0.00441	0.00441	CcSEcCtD
Hydroxychloroquine—Leukopenia—Dactinomycin—muscle cancer	0.00439	0.00439	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Etoposide—muscle cancer	0.00424	0.00424	CcSEcCtD
Hydroxychloroquine—Hepatocellular injury—Doxorubicin—muscle cancer	0.00421	0.00421	CcSEcCtD
Hydroxychloroquine—Anaemia—Vincristine—muscle cancer	0.00405	0.00405	CcSEcCtD
Hydroxychloroquine—Agitation—Vincristine—muscle cancer	0.00403	0.00403	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Methotrexate—muscle cancer	0.00402	0.00402	CcSEcCtD
Hydroxychloroquine—Oedema—Dactinomycin—muscle cancer	0.004	0.004	CcSEcCtD
Hydroxychloroquine—Aplastic anaemia—Doxorubicin—muscle cancer	0.00396	0.00396	CcSEcCtD
Hydroxychloroquine—Vertigo—Vincristine—muscle cancer	0.00394	0.00394	CcSEcCtD
Hydroxychloroquine—Leukopenia—Vincristine—muscle cancer	0.00392	0.00392	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Dactinomycin—muscle cancer	0.00392	0.00392	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Etoposide—muscle cancer	0.00386	0.00386	CcSEcCtD
Hydroxychloroquine—Anorexia—Dactinomycin—muscle cancer	0.00382	0.00382	CcSEcCtD
Hydroxychloroquine—Eye disorder—Etoposide—muscle cancer	0.00381	0.00381	CcSEcCtD
Hydroxychloroquine—Convulsion—Vincristine—muscle cancer	0.0038	0.0038	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00374	0.00374	CcSEcCtD
Hydroxychloroquine—Visual disturbance—Methotrexate—muscle cancer	0.00373	0.00373	CcSEcCtD
Hydroxychloroquine—Alopecia—Etoposide—muscle cancer	0.0036	0.0036	CcSEcCtD
Hydroxychloroquine—Oedema—Vincristine—muscle cancer	0.00358	0.00358	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Vincristine—muscle cancer	0.00351	0.00351	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Vincristine—muscle cancer	0.0035	0.0035	CcSEcCtD
Hydroxychloroquine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.0035	0.0035	CcSEcCtD
Hydroxychloroquine—Photosensitivity—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Dactinomycin—muscle cancer	0.00348	0.00348	CcSEcCtD
Hydroxychloroquine—Fatigue—Dactinomycin—muscle cancer	0.00345	0.00345	CcSEcCtD
Hydroxychloroquine—Pain—Dactinomycin—muscle cancer	0.00342	0.00342	CcSEcCtD
Hydroxychloroquine—Anorexia—Vincristine—muscle cancer	0.00341	0.00341	CcSEcCtD
Hydroxychloroquine—Irritability—Methotrexate—muscle cancer	0.00337	0.00337	CcSEcCtD
Hydroxychloroquine—Mood swings—Methotrexate—muscle cancer	0.00335	0.00335	CcSEcCtD
Hydroxychloroquine—Ataxia—Methotrexate—muscle cancer	0.00332	0.00332	CcSEcCtD
Hydroxychloroquine—Anaemia—Etoposide—muscle cancer	0.00328	0.00328	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00327	0.00327	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Methotrexate—muscle cancer	0.00326	0.00326	CcSEcCtD
Hydroxychloroquine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00324	0.00324	CcSEcCtD
Hydroxychloroquine—Dermatitis bullous—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Hydroxychloroquine—Vertigo—Etoposide—muscle cancer	0.00319	0.00319	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00318	0.00318	CcSEcCtD
Hydroxychloroquine—Leukopenia—Etoposide—muscle cancer	0.00318	0.00318	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Dactinomycin—muscle cancer	0.00317	0.00317	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Dactinomycin—muscle cancer	0.00317	0.00317	CcSEcCtD
Hydroxychloroquine—Hypoglycaemia—Doxorubicin—muscle cancer	0.00313	0.00313	CcSEcCtD
Hydroxychloroquine—Cardiac failure—Doxorubicin—muscle cancer	0.00313	0.00313	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Etoposide—muscle cancer	0.00312	0.00312	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Vincristine—muscle cancer	0.00311	0.00311	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00309	0.00309	CcSEcCtD
Hydroxychloroquine—Fatigue—Vincristine—muscle cancer	0.00308	0.00308	CcSEcCtD
Hydroxychloroquine—Convulsion—Etoposide—muscle cancer	0.00308	0.00308	CcSEcCtD
Hydroxychloroquine—Pain—Vincristine—muscle cancer	0.00306	0.00306	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Methotrexate—muscle cancer	0.00302	0.00302	CcSEcCtD
Hydroxychloroquine—Affect lability—Doxorubicin—muscle cancer	0.00301	0.00301	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.003	0.003	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Dactinomycin—muscle cancer	0.00295	0.00295	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Vincristine—muscle cancer	0.00293	0.00293	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Methotrexate—muscle cancer	0.0029	0.0029	CcSEcCtD
Hydroxychloroquine—Mood swings—Doxorubicin—muscle cancer	0.0029	0.0029	CcSEcCtD
Hydroxychloroquine—Ataxia—Doxorubicin—muscle cancer	0.00288	0.00288	CcSEcCtD
Hydroxychloroquine—Asthenia—Dactinomycin—muscle cancer	0.00287	0.00287	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Etoposide—muscle cancer	0.00284	0.00284	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Vincristine—muscle cancer	0.00283	0.00283	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Vincristine—muscle cancer	0.00283	0.00283	CcSEcCtD
Hydroxychloroquine—Liver function test abnormal—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Hydroxychloroquine—Skin disorder—Etoposide—muscle cancer	0.00282	0.00282	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Doxorubicin—muscle cancer	0.00279	0.00279	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Methotrexate—muscle cancer	0.00279	0.00279	CcSEcCtD
Hydroxychloroquine—Anorexia—Etoposide—muscle cancer	0.00276	0.00276	CcSEcCtD
Hydroxychloroquine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00275	0.00275	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Dactinomycin—muscle cancer	0.00274	0.00274	CcSEcCtD
Hydroxychloroquine—Drowsiness—Methotrexate—muscle cancer	0.00272	0.00272	CcSEcCtD
Hydroxychloroquine—Depression—Methotrexate—muscle cancer	0.00271	0.00271	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.0027	0.0027	CcSEcCtD
Hydroxychloroquine—Muscular weakness—Doxorubicin—muscle cancer	0.0027	0.0027	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Vincristine—muscle cancer	0.00264	0.00264	CcSEcCtD
Hydroxychloroquine—Eosinophilia—Doxorubicin—muscle cancer	0.00262	0.00262	CcSEcCtD
Hydroxychloroquine—Somnolence—Etoposide—muscle cancer	0.00258	0.00258	CcSEcCtD
Hydroxychloroquine—Asthenia—Vincristine—muscle cancer	0.00257	0.00257	CcSEcCtD
Hydroxychloroquine—Vomiting—Dactinomycin—muscle cancer	0.00255	0.00255	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Methotrexate—muscle cancer	0.00254	0.00254	CcSEcCtD
Hydroxychloroquine—Rash—Dactinomycin—muscle cancer	0.00252	0.00252	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Etoposide—muscle cancer	0.00252	0.00252	CcSEcCtD
Hydroxychloroquine—Pancytopenia—Doxorubicin—muscle cancer	0.00251	0.00251	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Etoposide—muscle cancer	0.0025	0.0025	CcSEcCtD
Hydroxychloroquine—Fatigue—Etoposide—muscle cancer	0.0025	0.0025	CcSEcCtD
Hydroxychloroquine—Pain—Etoposide—muscle cancer	0.00248	0.00248	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Methotrexate—muscle cancer	0.00246	0.00246	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Vincristine—muscle cancer	0.00245	0.00245	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Hydroxychloroquine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Hydroxychloroquine—Weight decreased—Doxorubicin—muscle cancer	0.00239	0.00239	CcSEcCtD
Hydroxychloroquine—Nausea—Dactinomycin—muscle cancer	0.00238	0.00238	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Etoposide—muscle cancer	0.00237	0.00237	CcSEcCtD
Hydroxychloroquine—Dizziness—Vincristine—muscle cancer	0.00237	0.00237	CcSEcCtD
Hydroxychloroquine—Drowsiness—Doxorubicin—muscle cancer	0.00236	0.00236	CcSEcCtD
Hydroxychloroquine—Visual impairment—Methotrexate—muscle cancer	0.00235	0.00235	CcSEcCtD
Hydroxychloroquine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00234	0.00234	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Hydroxychloroquine—Urticaria—Etoposide—muscle cancer	0.0023	0.0023	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Etoposide—muscle cancer	0.00229	0.00229	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Etoposide—muscle cancer	0.00229	0.00229	CcSEcCtD
Hydroxychloroquine—Eye disorder—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Hydroxychloroquine—Tinnitus—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Hydroxychloroquine—Vomiting—Vincristine—muscle cancer	0.00227	0.00227	CcSEcCtD
Hydroxychloroquine—Rash—Vincristine—muscle cancer	0.00226	0.00226	CcSEcCtD
Hydroxychloroquine—Dermatitis—Vincristine—muscle cancer	0.00225	0.00225	CcSEcCtD
Hydroxychloroquine—Headache—Vincristine—muscle cancer	0.00224	0.00224	CcSEcCtD
Hydroxychloroquine—Agranulocytosis—Doxorubicin—muscle cancer	0.0022	0.0022	CcSEcCtD
Hydroxychloroquine—Alopecia—Methotrexate—muscle cancer	0.00216	0.00216	CcSEcCtD
Hydroxychloroquine—Mental disorder—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Etoposide—muscle cancer	0.00214	0.00214	CcSEcCtD
Hydroxychloroquine—Malnutrition—Methotrexate—muscle cancer	0.00213	0.00213	CcSEcCtD
Hydroxychloroquine—Haemoglobin—Doxorubicin—muscle cancer	0.00213	0.00213	CcSEcCtD
Hydroxychloroquine—Nausea—Vincristine—muscle cancer	0.00213	0.00213	CcSEcCtD
Hydroxychloroquine—Haemorrhage—Doxorubicin—muscle cancer	0.00212	0.00212	CcSEcCtD
Hydroxychloroquine—Asthenia—Etoposide—muscle cancer	0.00208	0.00208	CcSEcCtD
Hydroxychloroquine—Pruritus—Etoposide—muscle cancer	0.00205	0.00205	CcSEcCtD
Hydroxychloroquine—Visual impairment—Doxorubicin—muscle cancer	0.00204	0.00204	CcSEcCtD
Hydroxychloroquine—Vision blurred—Methotrexate—muscle cancer	0.002	0.002	CcSEcCtD
Hydroxychloroquine—Erythema multiforme—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Etoposide—muscle cancer	0.00198	0.00198	CcSEcCtD
Hydroxychloroquine—Eye disorder—Doxorubicin—muscle cancer	0.00198	0.00198	CcSEcCtD
Hydroxychloroquine—Tinnitus—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Hydroxychloroquine—Anaemia—Methotrexate—muscle cancer	0.00197	0.00197	CcSEcCtD
Hydroxychloroquine—Dizziness—Etoposide—muscle cancer	0.00192	0.00192	CcSEcCtD
Hydroxychloroquine—Vertigo—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Hydroxychloroquine—Leukopenia—Methotrexate—muscle cancer	0.0019	0.0019	CcSEcCtD
Hydroxychloroquine—Alopecia—Doxorubicin—muscle cancer	0.00187	0.00187	CcSEcCtD
Hydroxychloroquine—Mental disorder—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Hydroxychloroquine—Convulsion—Methotrexate—muscle cancer	0.00184	0.00184	CcSEcCtD
Hydroxychloroquine—Vomiting—Etoposide—muscle cancer	0.00184	0.00184	CcSEcCtD
Hydroxychloroquine—Malnutrition—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Hydroxychloroquine—Rash—Etoposide—muscle cancer	0.00183	0.00183	CcSEcCtD
Hydroxychloroquine—Dermatitis—Etoposide—muscle cancer	0.00183	0.00183	CcSEcCtD
Hydroxychloroquine—Headache—Etoposide—muscle cancer	0.00182	0.00182	CcSEcCtD
Hydroxychloroquine—Tension—Doxorubicin—muscle cancer	0.00181	0.00181	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.0018	0.0018	CcSEcCtD
Hydroxychloroquine—Nervousness—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Hydroxychloroquine—Vision blurred—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Hydroxychloroquine—Nausea—Etoposide—muscle cancer	0.00172	0.00172	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Hydroxychloroquine—Anaemia—Doxorubicin—muscle cancer	0.0017	0.0017	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Hydroxychloroquine—Agitation—Doxorubicin—muscle cancer	0.00169	0.00169	CcSEcCtD
Hydroxychloroquine—Skin disorder—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Hydroxychloroquine—Vertigo—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Hydroxychloroquine—Anorexia—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Hydroxychloroquine—Leukopenia—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Hydroxychloroquine—Loss of consciousness—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Hydroxychloroquine—Convulsion—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Hydroxychloroquine—Somnolence—Methotrexate—muscle cancer	0.00154	0.00154	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Hydroxychloroquine—Oedema—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Hydroxychloroquine—Fatigue—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Hydroxychloroquine—Pain—Methotrexate—muscle cancer	0.00148	0.00148	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Hydroxychloroquine—Skin disorder—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Hydroxychloroquine—Anorexia—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Hydroxychloroquine—Urticaria—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Methotrexate—muscle cancer	0.00137	0.00137	CcSEcCtD
Hydroxychloroquine—Somnolence—Doxorubicin—muscle cancer	0.00134	0.00134	CcSEcCtD
Hydroxychloroquine—Decreased appetite—Doxorubicin—muscle cancer	0.00131	0.00131	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Hydroxychloroquine—Fatigue—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Hydroxychloroquine—Pain—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Methotrexate—muscle cancer	0.00128	0.00128	CcSEcCtD
Hydroxychloroquine—Asthenia—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Hydroxychloroquine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Hydroxychloroquine—Pruritus—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Hydroxychloroquine—Urticaria—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Hydroxychloroquine—Body temperature increased—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Hydroxychloroquine—Abdominal pain—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Hydroxychloroquine—Dizziness—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Hydroxychloroquine—Hypersensitivity—Doxorubicin—muscle cancer	0.00111	0.00111	CcSEcCtD
Hydroxychloroquine—Vomiting—Methotrexate—muscle cancer	0.0011	0.0011	CcSEcCtD
Hydroxychloroquine—Rash—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Hydroxychloroquine—Dermatitis—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Hydroxychloroquine—Headache—Methotrexate—muscle cancer	0.00109	0.00109	CcSEcCtD
Hydroxychloroquine—Asthenia—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Hydroxychloroquine—Pruritus—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Hydroxychloroquine—Nausea—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Hydroxychloroquine—Diarrhoea—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Hydroxychloroquine—Dizziness—Doxorubicin—muscle cancer	0.000994	0.000994	CcSEcCtD
Hydroxychloroquine—Vomiting—Doxorubicin—muscle cancer	0.000956	0.000956	CcSEcCtD
Hydroxychloroquine—Rash—Doxorubicin—muscle cancer	0.000948	0.000948	CcSEcCtD
Hydroxychloroquine—Dermatitis—Doxorubicin—muscle cancer	0.000947	0.000947	CcSEcCtD
Hydroxychloroquine—Headache—Doxorubicin—muscle cancer	0.000942	0.000942	CcSEcCtD
Hydroxychloroquine—Nausea—Doxorubicin—muscle cancer	0.000893	0.000893	CcSEcCtD
